Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,428,263
- Total 13F shares
- 26,122,191
- Share change
- -159,572
- Total reported value
- $47,560,467
- Put/Call ratio
- 0%
- Price per share
- $1.82
- Number of holders
- 46
- Value change
- +$748,885
- Number of buys
- 24
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03879J100:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
6,869,281
|
$6,938,000 | — | 31 Mar 2020 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
2.2%
|
4,331,020
|
$4,374,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
2,478,119
|
$2,503,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
2,047,008
|
$2,067,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.98%
|
1,938,329
|
$1,958,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.9%
|
1,774,815
|
$1,793,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.56%
|
1,113,024
|
$1,124,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.43%
|
847,164
|
$856,000 | — | 31 Mar 2020 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.41%
|
800,000
|
$808,000 | — | 31 Mar 2020 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.29%
|
580,100
|
$586,000 | — | 31 Mar 2020 | |
| Hound Partners, LLC |
13F
|
Company |
0.29%
|
574,551
|
$580,000 | — | 31 Mar 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.29%
|
565,522
|
$566,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
370,148
|
$374,000 | — | 31 Mar 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.18%
|
354,766
|
$358,000 | — | 31 Mar 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.14%
|
269,907
|
$273,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.11%
|
216,708
|
$219,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
212,400
|
$215,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
169,908
|
$172,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
134,000
|
$135,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
108,396
|
$109,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
103,671
|
$105,000 | — | 31 Mar 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
72,925
|
$73,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
54,549
|
$55,000 | — | 31 Mar 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
43,919
|
$44,000 | — | 31 Mar 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.02%
|
43,000
|
$43,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
42,243
|
$43,000 | — | 31 Mar 2020 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$40,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
28,026
|
$28,000 | — | 31 Mar 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
13,869
|
$14,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
12,243
|
$12,000 | — | 31 Mar 2020 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.01%
|
11,690
|
$12,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
11,686
|
$12,000 | — | 31 Mar 2020 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
11,700
|
$11,000 | — | 31 Mar 2020 | |
| Secure Asset Management, LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,000 | — | 31 Mar 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.01%
|
9,900
|
$9,000 | — | 31 Mar 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
5,476
|
$6,000 | — | 31 Mar 2020 | |
| Sterling Investment Advisors, Ltd. |
13F
|
Company |
0%
|
4,000
|
$4,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,046
|
$3,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,900
|
$3,000 | — | 31 Mar 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,413
|
$3,000 | — | 31 Mar 2020 | |
| HARBOR INVESTMENT ADVISORY, LLC |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 31 Mar 2020 | |
| SIMON QUICK ADVISORS, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
800
|
$808 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
70
|
$71 | — | 31 Mar 2020 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2020
As of 30 Jun 2020,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,122,191 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, MORGAN STANLEY, VANGUARD GROUP INC, ADVISOR GROUP HOLDINGS, INC., GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, Hudson Bay Capital Management LP, PRIMECAP MANAGEMENT CO/CA/, and BANK OF MONTREAL /CAN/.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
44
Q2 2020 holders
46
Holder diff
2
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.